A list of the latest medical information from Seagull Pharmacy

Current Location：Home>Medical Information

Medication Adherence Issues Affect CVD Management
2022-02-15 13:28:14
Cardiovascular ardiovascular disease (CVD) encompasses several disorders of the blood vessels and heart, including cerebrovascular, congenital he...
Coronavirus (COVID-19) Update: FDA Authorizes New Monoclonal Antibody for Treatment of COVID-19 that Retains Activity Against Omicron Variant
2022-02-15 11:11:58
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for a new monoclonal antibody for the treatment of COVID...
Cemiplimab Achieves Promising Survival in Recurrent Cervical Cancer
2022-02-15 11:01:30
Treatment with cemiplimab ( Libtayo ) resulted in significantly longer survival compared with single agent chemotherapy in patients with recurr...
ASCO GU: AstraZeneca, Merck’s Lynparza one-ups J&J’s Zejula with prostate cancer win regardless of gene mutations
2022-02-15 10:51:03
AstraZeneca and Merck Co.’s Lynparza may have a narrower label than GlaxoSmithKline’s rival drug Zejula in ovarian cancer, but in prostate c...
Apalutamide Combo Improves Radiographic PFS in mCRPC
2022-02-11 14:22:07
Patients with metastatic castration-resistant prostate cancer experienced an improved radiographic progression-free survival (PFS) following trea...
Trend Identified Favoring First-Line Trifluridine/Tipiracil Plus Bevacizumab in Metastatic CRC
2022-02-11 14:15:16
Despite not demonstrating statistically significant superiority in progression-free survival (PFS) for patients with metastatic colorectal cancer...
Approved Medications Can Stimulate Weight Loss
2022-02-11 14:05:54
The traditional formula for weight loss is simple: induce a negative energy balance by increasing physical activities and reducing caloric intake...
A Look at Multiple Myeloma Treatment Options in the Pipeline
2022-02-11 13:57:47
According to the American Cancer Society, approximately 12,000 deaths were caused by multiple myeloma (MM) in 2021. Current drug therapies on the...
FDA Approves Enjaymo for Treatment of Cold Agglutinin Disease
2022-02-10 16:56:47
The FDA has approved sutimlimab-jome (Enjaymo, Sanofi) to decrease the need for red blood cell transfusion because of hemolysis in adults with co...
Larotrectinib Treats NTRK Gene Fusion-Positive Cancers Successfully With Low Rates of Adverse Effects
2022-02-10 16:43:09
Larotrectinib ( Vitrakvi ) is a tyrosine kinase receptor (TRK) inhibitor indicated for the treatment of metastatic or unresectable neurotrophic...

<<
<
29
30
31
>
>>
Jump to Page